PMID- 12535738 OWN - NLM STAT- MEDLINE DCOM- 20030604 LR - 20190718 IS - 0021-9150 (Print) IS - 0021-9150 (Linking) VI - 166 IP - 2 DP - 2003 Feb TI - Electronegative LDL of FH subjects: chemical characterization and induction of chemokine release from human endothelial cells. PG - 261-70 AB - Electronegative LDL (LDL(-)) constitutes a plasma subfraction of LDL with proinflammatory properties. Its proportion is increased in familial hypercholesterolemia (FH); however, the characteristics of LDL(-) isolated from FH subjects have not been previously studied. In this work, the composition, oxidative status, and inflammatory capacity on endothelial cells of LDL(-) from FH and normolipemic (NL) subjects were evaluated. LDL(-) from FH was relatively enriched in esterified and free cholesterol and triglyceride, and had lower apoB and phospholipid content compared with the non-electronegative fraction (LDL(+)). LDL(-) also contained increased amounts of apoE, apoC-III, sialic acid, and non-esterified fatty acids (NEFAs). The same was observed in NL subjects, except that esterified cholesterol and phospholipid were similar in LDL(-) and LDL(+). No difference was observed between the two fractions concerning malondialdehyde, fatty acid hydroxides, and antioxidants, thereby indicating the absence of increased oxidation of LDL(-) compared with LDL(+). When LDL(-) (100 mg/l) from NL and FH subjects was incubated for 24 h with human umbilical vein endothelial cells (HUVECs), interleukin 8 (IL-8) and monocyte chemotactic protein 1 (MCP-1) increased twofold in the culture medium compared with LDL(+). Vascular cell adhesion molecule 1 (VCAM-1) expression was not increased by LDL(-). Our data indicate that LDL(-) from FH or NL subjects shows no evidence of increased oxidative modification compared to LDL(+); however, LDL(-) induces twofold the release of chemokines by endothelial cells. This effect, which may contribute to leukocyte recruitment and promote atherogenesis, may be greater in FH subjects in which LDL(-) can be up to eightfold higher than in NL subjects. FAU - Sanchez-Quesada, Jose Luis AU - Sanchez-Quesada JL AD - Servei de Bioquimica del Hospital de la Santa Creu i Sant Pau (HSCSP), C/Antoni Maria Claret 167, 08025 Barcelona, Spain. FAU - Camacho, Mercedes AU - Camacho M FAU - Anton, Rosa AU - Anton R FAU - Benitez, Sonia AU - Benitez S FAU - Vila, Lluis AU - Vila L FAU - Ordonez-Llanos, Jordi AU - Ordonez-Llanos J LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Ireland TA - Atherosclerosis JT - Atherosclerosis JID - 0242543 RN - 0 (Chemokine CCL2) RN - 0 (Interleukin-8) RN - 0 (Lipoproteins, LDL) RN - 0 (Vascular Cell Adhesion Molecule-1) SB - IM MH - Blotting, Western MH - Cells, Cultured MH - Chemokine CCL2/analysis MH - Endothelium, Vascular/*cytology MH - Enzyme-Linked Immunosorbent Assay MH - Humans MH - Hyperlipoproteinemia Type II/*blood/*physiopathology MH - Interleukin-8/analysis MH - Lipoproteins, LDL/*analysis/*chemistry MH - Probability MH - Reference Values MH - Statistics, Nonparametric MH - Vascular Cell Adhesion Molecule-1/*analysis EDAT- 2003/01/22 04:00 MHDA- 2003/06/05 05:00 CRDT- 2003/01/22 04:00 PHST- 2003/01/22 04:00 [pubmed] PHST- 2003/06/05 05:00 [medline] PHST- 2003/01/22 04:00 [entrez] AID - S0021-9150(02)00374-X [pii] AID - 10.1016/s0021-9150(02)00374-x [doi] PST - ppublish SO - Atherosclerosis. 2003 Feb;166(2):261-70. doi: 10.1016/s0021-9150(02)00374-x.